Q3 2026 13F filing
Updated 6 days ago111 disclosed positions worth $1.9B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | U UNITED THERAPEUTICS CORP DEL | $176M | 324.7K | 9.46% | — |
| 2 | E ENCOMPASS HEALTH CORP | $131.5M | 1.08M | 7.07% | — |
| 3 | E ENSIGN GROUP INC | $124.9M | 726.2K | 6.71% | — |
| 4 | A ABIVAX SA | $109M | 1.10M | 5.86% | — |
| 5 | Q INVESCO QQQ TR | $99.9M | 135.0K | 5.37% | — |
| 6 | V VERA THERAPEUTICS INC | $76.3M | 2.36M | 4.10% | — |
| 7 | R REVVITY INC | $68.8M | 449.8K | 3.70% | — |
| 8 | N NATERA INC | $53M | 128.1K | 2.85% | — |
| 9 | C CARETRUST REIT INC | $49.5M | 1.35M | 2.66% | — |
| 10 | O OMEGA HEALTHCARE INVS INC | $46.7M | 1.01M | 2.51% | — |
| 11 | S SYNDAX PHARMACEUTICALS INC | $45.9M | 2.44M | 2.47% | — |
| 12 | G GUARDANT HEALTH INC | $45.7M | 256.4K | 2.46% | — |
| 13 | C CELLDEX THERAPEUTICS INC NEW | $38.1M | 1.17M | 2.05% | — |
| 14 | W WATERS CORP | $33.1M | 75.4K | 1.78% | — |
| 15 | V VIKING THERAPEUTICS INC | $32.8M | 1.01M | 1.76% | — |
| 16 | B BROOKDALE SR LIVING INC | $31.1M | 2.87M | 1.67% | — |
| 17 | H HCA HEALTHCARE INC | $29.2M | 68.3K | 1.57% | — |
| 18 | P VAXCYTE INC | $29M | 509.2K | 1.56% | — |
| 19 | T TRAVERE THERAPEUTICS INC | $26.7M | 453.9K | 1.44% | — |
| 20 | C COMMUNITY HEALTH SYS INC NEW | $26.1M | 9.14M | 1.40% | — |
| 21 | G GRAIL INC | $25.5M | 182.2K | 1.37% | — |
| 22 | G GERON CORP | $22.8M | 18.53M | 1.23% | — |
| 23 | C CHEMED CORP NEW | $22.2M | 43.9K | 1.19% | — |
| 24 | P PENNANT GROUP INC | $20.9M | 536.1K | 1.12% | — |
| 25 | L LTC PPTYS INC | $19.6M | 458.0K | 1.06% | — |
| 26 | B BETA BIONICS INC | $19.4M | 1.02M | 1.04% | — |
| 27 | L LIQUIDIA CORPORATION | $19.4M | 642.0K | 1.04% | — |
| 28 | I INSMED INC | $18.4M | 160.8K | 0.99% | — |
| 29 | B BIOMARIN PHARMACEUTICAL INC | $18.3M | 304.8K | 0.98% | — |
| 30 | B BRUKER CORP | $18.1M | 279.9K | 0.97% | — |
| 31 | T TENET HEALTHCARE CORP | $18M | 70.4K | 0.97% | — |
| 32 | G GOODRX HLDGS INC | $16.5M | 5.02M | 0.89% | — |
| 33 | C COGENT BIOSCIENCES INC | $15.4M | 480.1K | 0.83% | — |
| 34 | R ROIVANT SCIENCES LTD | $15.3M | 419.1K | 0.82% | — |
| 35 | S STATE STR SPDR S&P 500 ETF T | $15.3M | 20.0K | 0.82% | — |
| 36 | S SUPERNUS PHARMACEUTICALS | $15M | 347.9K | 0.80% | — |
| 37 | P INSULET CORP | $13.2M | 101.0K | 0.71% | — |
| 38 | R REPLIGEN CORP | $12.5M | 64.8K | 0.67% | — |
| 39 | R RELAY THERAPEUTICS INC | $12.3M | 681.7K | 0.66% | — |
| 40 | W WELLTOWER INC | $10.6M | 46.2K | 0.57% | — |
| 41 | A ARROWHEAD PHARMACEUTICALS IN | $10.2M | 156.2K | 0.55% | — |
| 42 | T TARSUS PHARMACEUTICALS INC | $10.2M | 129.3K | 0.55% | — |
| 43 | C CYTOMX THERAPEUTICS INC. | $9.6M | 3.54M | 0.52% | — |
| 44 | S SUMMIT THERAPEUTICS INC | $8.9M | 526.6K | 0.48% | — |
| 45 | P PACS GROUP INC | $8.8M | 211.7K | 0.47% | — |
| 46 | P PHARVARIS N V | $8.4M | 265.1K | 0.45% | — |
| 47 | A ANAPTYSBIO INC | $7.8M | 154.9K | 0.42% | — |
| 48 | M MOLINA HEALTHCARE INC | $7.4M | 39.4K | 0.40% | — |
| 49 | R ULTRAGENYX PHARMACEUTICAL IN | $7.3M | 484.1K | 0.39% | — |
| 50 | S SONIDA SENIOR LIVING INC | $7.3M | 193.2K | 0.39% | — |